Cargando…
Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364496/ https://www.ncbi.nlm.nih.gov/pubmed/35948979 http://dx.doi.org/10.1186/s12943-022-01632-7 |
| _version_ | 1784765156200284160 |
|---|---|
| author | Ouyang, Qing Gong, Xueyang Xiao, Hualiang Zhou, Ji Xu, Minhui Dai, Yun Xu, Lunshan Feng, Hua Cui, Hongjuan Yi, Liang |
| author_facet | Ouyang, Qing Gong, Xueyang Xiao, Hualiang Zhou, Ji Xu, Minhui Dai, Yun Xu, Lunshan Feng, Hua Cui, Hongjuan Yi, Liang |
| author_sort | Ouyang, Qing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9364496 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93644962022-08-11 Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients Ouyang, Qing Gong, Xueyang Xiao, Hualiang Zhou, Ji Xu, Minhui Dai, Yun Xu, Lunshan Feng, Hua Cui, Hongjuan Yi, Liang Mol Cancer Correction BioMed Central 2022-08-10 /pmc/articles/PMC9364496/ /pubmed/35948979 http://dx.doi.org/10.1186/s12943-022-01632-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Ouyang, Qing Gong, Xueyang Xiao, Hualiang Zhou, Ji Xu, Minhui Dai, Yun Xu, Lunshan Feng, Hua Cui, Hongjuan Yi, Liang Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients |
| title | Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients |
| title_full | Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients |
| title_fullStr | Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients |
| title_full_unstemmed | Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients |
| title_short | Correction: Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients |
| title_sort | correction: neurotensin promotes the progression of malignant glioma through ntsr1 and impacts the prognosis of glioma patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364496/ https://www.ncbi.nlm.nih.gov/pubmed/35948979 http://dx.doi.org/10.1186/s12943-022-01632-7 |
| work_keys_str_mv | AT ouyangqing correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT gongxueyang correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT xiaohualiang correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT zhouji correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT xuminhui correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT daiyun correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT xulunshan correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT fenghua correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT cuihongjuan correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients AT yiliang correctionneurotensinpromotestheprogressionofmalignantgliomathroughntsr1andimpactstheprognosisofgliomapatients |